Hormone Replacement and Anti-Aging Center
The Most Effective Weight Loss Medication Ever Available is NOW at Cleveland Health Group.
Tirzepatide, the active ingredient in FDA approved Mounjaro® and Zepbound™ is a once-weekly injection to decrease blood sugar. Since 2022 it has shown remarkable weight-loss effects, and is on fast-track designation for its review for the treatment of obesity. On average patients saw an astounding weight-loss of over 20% of their initial body weight.
Cleveland Health Group’s exclusive combination of Tirzepatide and B6 helps with weight loss by decreasing food intake and slowing down how fast food travels through your digestive tract. This may help you feel fuller longer and reduce how much food you eat. Studies show this action may occur in the brain.
Lifestyle modifications and calorie restriction will lead to overall better results. Benefits of weight loss are: improved comorbidities of obesity such as diabetes, high blood pressure, abnormal blood lipids and heart disease which can be seen with as little as a 5% weight loss.
The most common side effects of Tirzepatide include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain. These are not all the possible side effects of Mounjaro. Talk to your healthcare provider about any side effects you might experience.
Here at Cleveland Health Group we are always available to take your call and answer your commonly asked questions about the popular weight loss drugs Semaglutide and Tirzepatide. Here are some FAQs to help our patients learn more about these state-of-the-art treatments so you can make a well-informed decision.
Tirzepatide is a once weekly injection that is FDA approved to decrease blood sugar. Since 2022 the active ingredient in Mounjaro has shown remarkable weight loss effects and is on the fast-track designation for its review for the treatment of obesity. Cleveland Health Group’s exclusive combination of Tirzepatide, BPC-157, and B6 helps with weight loss by decreasing food intake and slowing down how fast food travels through your digestive tract.
Semaglutide is a once weekly injection that works by increasing insulin levels in your body, which decreases your blood sugar. It also reduces the amount of sugar released into the blood and slows down digestion. This process helps to limit food intake, reduces appetite, all while curbing food cravings and altering food preferences. This exclusive compound for Cleveland Health Group is similar to a natural hormone in your body that causes insulin release in response to high blood sugar.
Tirzepatide acts on BOTH GIP and GLP-1 receptors, while Semaglutide acts only on GLP-1 receptors. Both drugs are effective weight-loss treatments. Tirzepatide is a dual-acting GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. Both are in the class of drugs known as incretin mimetics but have some differences.
Patients who struggle with weight and overconsumption issues are good candidates for Semaglutide or Tirzepatide treatments. To qualify for Semaglutide or Tirzepatide treatment, candidates must have a BMI of 30 or higher. If the patient has a BMI in the range of 27 to 29, but also suffers from weight-related comorbidities, they would likely be eligible for treatment.
These medications work by essentially reducing the appetite of patients, which results in lower caloric intake. As a result, patients have less desire to eat more than they should, thus removing one of the biggest barriers to effective weight management.
These treatments also help patients from getting hungry too soon. They don’t feel the need to eat more often throughout the day or give in to their cravings. Even food preferences can be affected. Patients are more likely to want foods that are healthier for them.
Typically, patients taking Semaglutide or Tirzepatide achieve a 15% to 20% reduction in body weight.
Semaglutide and Tirzepatide must be injected once per week. The dosage will be very low at the start and will gradually increase. This reduces the possibility of side-effects.
Not everyone will experience side-effects during treatment. Mild discomfort around the injection area is possible. Some patients have reported nausea or constipation, which can reduce in frequency with continued treatment.
As with any weight-loss treatment, patience is key. Everyone is different. The process is gradual and involves slowly increasing the dosage with time. Many patients experience changes in the first few weeks after beginning their treatment process.
Here at Cleveland Health Group we value your time and money. We have made it our mission to make our servies affordable to everyone. Each weekly injection of Semaglutide is $50. Each weekly injection of Tirzepatide is $75.
Cleveland Health Group can only treat Ohio residents.
Yes. Cleveland Health Group offers convenient virtual consultations with the option to purchase an entire vial of Semaglutide or Tirzepaide for at-home distribution.
Cleveland Health Group offers two convenient choices for Ohio residents to get in on this revolutionary weight loss option.
Pricing starts at $75 per injection at our Independence location including follow-up consultations and weight loss monitoring. You can also opt for a virtual consultation to see if treatment can be done in the comfort of your own home.
Call 216-927-9900 or visit clevelandhealthgroup.com to schedule your complimentary consultation.